生化学工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4548/E00970 | SEIKAGAKU CORPORATION |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/01/14 | 日証協 | 115,937株 | 0% | 900株 | +2332.43% | 263,015株 | +1.26% | 34,812株 | -59.89% |
2022/01/07 | 日証協 | 115,937株 | -23.45% | 37株 | -99.76% | 259,752株 | -11.54% | 86,796株 | +51.52% |
2021/12/30 | 日証協 | 151,450株 | 0% | 15,700株 | 0% | 293,644株 | 0% | 57,285株 | 0% |
2021/12/24 | 日証協 | 151,450株 | -53.09% | 15,700株 | -83.32% | 293,644株 | -36.1% | 57,285株 | -50.19% |
2021/12/17 | 日証協 | 322,850株 | -20.88% | 94,100株 | +49.84% | 459,507株 | -38.84% | 114,996株 | +2.15% |
2021/12/10 | 日証協 | 408,050株 | -2.88% | 62,800株 | +10.66% | 751,307株 | +3.91% | 112,571株 | +10.53% |
2021/12/03 | 日証協 | 420,150株 | +6.87% | 56,748株 | +12.15% | 723,036株 | +6.62% | 101,848株 | +188.95% |
2021/11/26 | 日証協 | 393,150株 | +3.72% | 50,598株 | +425.8% | 678,136株 | +3.17% | 35,248株 | +43.28% |
2021/11/19 | 日証協 | 379,050株 | -0.05% | 9,623株 | -83.69% | 657,317株 | -0.68% | 24,600株 | +6.85% |
2021/11/05 | 日証協 | 385,550株 | 0% | 56,200株 | -47.53% | 677,194株 | +0.76% | 19,080株 | +6.59% |
2021/10/29 | 日証協 | 385,550株 | +0.47% | 107,100株 | +88.89% | 672,095株 | -1.36% | 17,901株 | -60.74% |
2021/10/22 | 日証協 | 383,750株 | +1.84% | 56,700株 | -67.13% | 681,394株 | -0.16% | 45,600株 | -73.28% |
2021/10/15 | 日証協 | 376,814株 | +35.81% | 172,500株 | +92.41% | 682,458株 | +16% | 170,643株 | +122.45% |
2021/10/08 | 日証協 | 277,450株 | +3.16% | 89,650株 | -3.29% | 588,305株 | +5.71% | 76,710株 | -56.86% |
2021/10/01 | 日証協 | 268,959株 | +28.99% | 92,700株 | +163.35% | 556,542株 | +10.32% | 177,825株 | +532.02% |
2021/09/24 | 日証協 | 208,506株 | -9.44% | 35,200株 | -81.97% | 504,480株 | -4.93% | 28,136株 | -91.95% |
2021/09/17 | 日証協 | 230,247株 | +294.58% | 195,254株 | +1135.78% | 530,644株 | +131.87% | 349,551株 | +594.56% |
2021/09/10 | 日証協 | 58,352株 | +19.45% | 15,800株 | -48.53% | 228,851株 | +5.91% | 50,327株 | +1.08% |
2021/09/03 | 日証協 | 48,852株 | +6.78% | 30,700株 | +567.39% | 216,074株 | +5.88% | 49,787株 | -9.86% |
※株式分割は考慮していませんのでご注意ください。
Page Top